Medicine & Life Sciences
Sickle Cell Anemia
100%
Heparin Cofactor II
91%
Thrombin
53%
Dermatan Sulfate
48%
Heparin
36%
Iron
34%
Rituximab
31%
Leukotriene E4
28%
cysteinyl-leukotriene
27%
Chelation Therapy
26%
Thrombotic Thrombocytopenic Purpura
25%
Hemorrhage
24%
Arginine
23%
Hemoglobins
23%
Reticulocytes
23%
Physiological Stress
22%
Therapeutics
21%
Venous Thrombosis
21%
Lysine
21%
Acute Chest Syndrome
21%
human SERPIND1 protein
20%
Sickle Cell Trait
19%
Catalytic Domain
19%
Bone Marrow
17%
Plasmapheresis
17%
Glycosaminoglycans
17%
Warfarin Sensitivity
17%
Mutation
17%
Pain
16%
Factor XI Deficiency
15%
Immunoglobulin G
15%
Mezlocillin
15%
Catheters
15%
Deferasirox
15%
Drug Therapy
14%
Acute Intermittent Porphyria
14%
Ticarcillin
14%
Factor XI
14%
Myelodysplastic Syndromes
13%
Warfarin
13%
Cefoperazone
13%
Hydroxyurea
13%
Idiopathic Thrombocytopenic Purpura
13%
Bone Marrow Failure Disorders
13%
Site-Directed Mutagenesis
12%
von Willebrand Diseases
12%
Piperacillin
12%
Meconium
12%
Humeral Head
12%
Cefazolin
12%
Chemical Compounds
Heparin
59%
Cofactor
52%
Dermatan Sulfate
43%
Thrombin
32%
Arginine
27%
Inhibition of Thrombin
22%
Lysine
21%
Hemoglobin
17%
Mutation
17%
Cellular Volume
17%
Ferritin
15%
Complementary DNA
14%
Hydroxyurea
13%
Nucleotide Sequence
11%
Site-Directed Mutagenesis
10%
Substitution Reaction
8%
Glycosaminoglycan
8%
Proline
8%
Polypeptide
7%
Metabolic
7%
Heterodimer
7%
Peptide
7%
Antithrombin
6%
Length
6%
Hydrolysis
5%
Disorder
5%
Acid
5%
Poly(ethylene Glycol)
5%
Plasma
5%